Free Trial
→ Trump’s Secret Weapon (From American Alternative) (Ad) Buy EPIX Stock  Free EPIX Stock Alerts

ESSA Pharma (EPIX) Institutional Ownership

ESSA Pharma logo
$1.79 +0.02 (+1.13%)
Closing price 04/17/2025 04:00 PM Eastern
Extended Trading
$1.80 +0.00 (+0.28%)
As of 04/17/2025 04:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Institutional Ownership Changes (13F Filings) for ESSA Pharma (NASDAQ:EPIX)

Current
Institutional Ownership
Percentage
75.12%
Number of
Institutional Buyers
(last 12 months)
23
Total
Institutional Inflows
(last 12 months)
$28.78M
Number of
Institutional Sellers
(last 12 months)
6
Total
Institutional Outflows
(last 12 months)
$9.50M
Get EPIX Insider Trade Alerts

Want to know when executives and insiders are buying or selling ESSA Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

EPIX Institutional Buying and Selling by Quarter

ESSA Pharma Major Shareholders & Ownership History

Export to Excel
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/18/2025GTS Securities LLC16,700$30K0.0%N/A0.038%
2/17/2025Soleus Capital Management L.P.2,262,026$4.05M0.3%-47.2%5.096%
2/17/2025Squarepoint Ops LLC14,525$26K0.0%N/A0.033%
2/17/2025Two Sigma Advisers LP82,600$148K0.0%N/A0.186%
2/17/2025Two Sigma Investments LP211,204$378K0.0%N/A0.476%
2/17/2025Tang Capital Management LLC4,300,000$7.70M0.5%N/A9.687%
2/17/2025RTW Investments LP1,113,002$1.99M0.0%-65.9%2.507%
2/17/2025Cubist Systematic Strategies LLC26,287$47K0.0%N/A0.059%
2/17/2025Bank of America Corp DE812,310$1.45M0.0%+10,153,775.0%1.830%
2/17/2025BNP Paribas Financial Markets164,595$295K0.0%+269.9%0.371%
2/14/2025Jane Street Group LLC45,810$82K0.0%N/A0.103%
2/14/2025Schonfeld Strategic Advisors LLC48,843$87K0.0%-82.4%0.110%
2/14/2025Vazirani Asset Management LLC50,000$90K0.3%N/A0.113%
2/14/2025Two Sigma Securities LLC15,943$29K0.0%N/A0.036%
2/14/2025Altium Capital Management LLC1,428,000$2.56M0.7%N/A3.217%
2/13/2025Marshall Wace LLP181,217$324K0.0%N/A0.408%
2/13/2025XTX Topco Ltd37,526$67K0.0%N/A0.085%
2/12/2025Aldebaran Capital LLC397,523$712K0.7%N/A0.896%
2/7/2025Lepercq Multi Asset Fund30,200$54K0.0%N/A0.068%
2/7/2025BML Capital Management LLC4,221,546$7.56M4.7%N/A9.510%
1/17/2025 Magnus Financial Group LLC55,206$99K0.0%N/A0.124%
1/13/2025 FNY Investment Advisers LLC25,000$44K0.0%N/A0.056%
11/15/2024RTW Investments LP3,261,496$19.77M0.3%+41.9%7.351%
11/15/2024Parkman Healthcare Partners LLC345,902$2.10M0.3%+37.2%0.780%
11/14/2024Bellevue Group AG7,879,583$47.75M0.8%-0.1%17.759%
11/14/2024PFM Health Sciences LP2,742,936$16.62M0.9%-7.5%6.182%
5/16/2024Janus Henderson Group PLC1,175,242$9.98M0.0%+7.9%2.657%
5/15/2024Bellevue Group AG7,889,583$66.98M1.0%-0.1%17.834%
5/14/2024EntryPoint Capital LLC4,420$38K0.0%N/A0.010%
5/1/2024BNP Paribas Financial Markets42,495$361K0.0%-26.1%0.096%
2/15/2024PFM Health Sciences LP3,262,500$21.53M1.3%-22.3%7.388%
2/14/2024RTW Investments LP2,298,662$15.17M0.2%N/A5.205%
2/7/2024BNP Paribas Financial Markets57,466$379K0.0%+164.9%0.130%
11/15/2023Rock Springs Capital Management LP677,005$2.09M0.1%+2.1%1.535%
11/9/2023Group One Trading L.P.41,860$129K0.0%-14.2%0.095%
11/9/2023Rhenman & Partners Asset Management AB234,000$723K0.1%-34.4%0.531%
8/14/2023Rock Springs Capital Management LP663,317$1.79M0.0%+26.4%1.504%
8/14/2023Driehaus Capital Management LLC28,300$76K0.0%-89.3%0.064%
8/11/2023Cibc World Market Inc.160,643$434K0.0%-23.1%0.364%
7/26/2023Privium Fund Management B.V.20,032$55K0.0%N/A0.045%
Now I look stupid. Real stupid... (Ad)

I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

Here’s the full story for you.
5/16/2023Ally Bridge Group NY LLC236,583$703K0.9%-70.8%0.537%
5/12/2023Rhenman & Partners Asset Management AB356,500$1.05M0.1%-4.9%0.809%
5/3/2023Privium Fund Management UK Ltd20,032$61K0.0%N/A0.045%
2/15/2023Avidity Partners Management LP1,855,400$4.68M0.1%-24.6%4.208%
2/14/2023Driehaus Capital Management LLC264,571$667K0.0%N/A0.600%
2/3/2023Frazier Life Sciences Management L.P.605,141$1.53M0.1%-12.7%1.373%
11/15/2022PFM Health Sciences LP1,478,252$2.69M0.1%+53.7%3.354%
11/15/2022Eventide Asset Management LLC1,561,251$2.84M0.1%-53.6%3.543%
11/15/2022BVF Inc. IL8,748,629$15.92M0.7%+136.5%19.852%
11/15/2022Bellevue Group AG5,898,583$10.74M0.2%+17.7%13.385%
11/15/2022Bioimpact Capital LLC405,700$738K0.2%-38.6%0.921%
11/14/2022RTW Investments LP1,311,294$2.39M0.1%-50.3%2.975%
11/10/2022AlpInvest Partners B.V.39,930$73K0.0%-62.5%0.091%
8/12/2022Ensign Peak Advisors Inc26,282$83K0.0%-70.6%0.060%
8/11/2022Trexquant Investment LP19,147$60K0.0%+24.3%0.043%
8/11/2022Alps Advisors Inc.26,140$82K0.0%N/A0.059%
8/10/2022Cibc World Market Inc.94,578$298K0.0%-17.9%0.215%
8/8/2022Walleye Capital LLC104,393$329K0.0%+75.8%0.237%
8/3/2022Candriam S.C.A.567,343$1.79M0.0%-3.5%1.289%
5/17/2022Eventide Asset Management LLC4,170,259$25.77M0.4%+25.7%9.474%
5/16/2022Blackstone Inc.2,003,103$12.38M0.0%-39.4%4.551%
5/16/2022Frazier Life Sciences Management L.P.692,910$4.28M0.4%N/A1.574%
5/9/2022Qube Research & Technologies Ltd47,655$295K0.0%N/A0.108%
5/4/2022Prospera Financial Services Inc7,568$47K0.0%N/A0.017%
5/2/2022Cannon Global Investment Management LLC15,300$95K0.1%N/A0.035%
4/27/2022Alta Wealth Advisors LLC11,285$70K0.0%N/A0.026%
3/10/2022Values First Advisors Inc.13,668$194K0.1%N/A0.031%
2/19/2022Woodline Partners LP684,247$9.72M0.1%+286.6%1.556%
2/15/2022CIBC World Markets Inc.84,230$1.20M0.0%N/A0.192%
2/14/2022Virtus ETF Advisers LLC13,643$194K0.1%+74.3%0.031%
2/14/2022Altium Capital Management LP345,000$4.90M1.4%N/A0.784%
2/14/2022Boxer Capital LLC724,500$10.29M0.4%+5.5%1.647%
2/14/2022Soleus Capital Management L.P.3,525,457$50.06M5.0%+22.9%8.015%
2/14/2022Eventide Asset Management LLC3,318,647$47.13M0.6%+52.2%7.545%
2/11/2022Ensign Peak Advisors Inc89,448$1.27M0.0%+7.7%0.203%
2/11/2022Bioimpact Capital LLC668,688$9.50M1.7%-2.1%1.520%
2/10/2022Candriam Luxembourg S.C.A.626,276$8.89M0.1%+108.4%1.424%
2/8/2022Frazier Management LLC543,470$7.72M0.6%+51.7%1.236%
2/8/2022Swiss National Bank53,200$755K0.0%+8.4%0.121%
2/3/2022Advisor Group Holdings Inc.4,559$65K0.0%-28.8%0.010%
12/17/2021Jefferies Group LLC62,502$500K0.0%N/A0.142%
11/16/2021Schonfeld Strategic Advisors LLC10,600$85K0.0%-87.8%0.024%
11/16/2021Janus Henderson Group PLC3,477,844$27.84M0.0%+72.4%7.907%
11/16/2021Two Sigma Advisers LP564,800$4.52M0.0%+1,319.1%1.284%
11/16/2021Two Sigma Investments LP502,406$4.02M0.0%+1,658.9%1.142%
11/16/2021BVF Inc. IL2,851,461$22.81M0.9%+16.3%6.483%
11/16/2021BioImpact Capital LLC683,287$5.47M0.8%N/A1.553%
11/16/2021Citadel Advisors LLC685,531$5.49M0.0%-4.9%1.559%
11/15/2021RTW Investments LP2,637,192$21.10M0.3%-13.6%5.996%
11/15/2021Rock Springs Capital Management LP508,044$4.06M0.1%+1.0%1.155%
Trump and Musk fight back (Ad)

Is there more to the Musk–Trump relationship than meets the eye? Jeff Brown thinks so — and he believes it has to do with a top-level initiative to build the ultimate military-grade AI system. He’s calling it the “AI Superweapon,” and he says it could soon become the center of global tech dominance. At the core of this initiative? A handful of companies tied to America’s most powerful tech platforms — and investors who act before this goes mainstream may have a rare early edge.

Click here to see why Jeff believes this is the biggest stock story of the year — and which companie
11/15/2021Sphera Funds Management LTD.469,402$3.76M0.3%-27.6%1.067%
11/15/2021HighVista Strategies LLC143,566$1.15M0.8%+497.5%0.326%
11/15/2021Ensign Peak Advisors Inc83,068$665K0.0%-53.4%0.189%
11/12/2021Renaissance Technologies LLC141,500$1.13M0.0%+618.3%0.322%
11/12/2021Macquarie Group Ltd.6,106$49K0.0%N/A0.014%
11/12/2021Credit Suisse AG13,713$110K0.0%+12.2%0.031%
11/12/2021Oppenheimer & Co. Inc.47,300$378K0.0%N/A0.108%
11/12/2021Bellevue Group AG5,034,814$40.28M0.4%+104.7%11.447%
11/12/2021Rhenman & Partners Asset Management AB600,000$4.80M0.3%+130.8%1.364%
11/10/2021Goldman Sachs Group Inc.121,601$973K0.0%+82.1%0.276%
(Data available from 1/1/2016 forward)

EPIX Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of EPIX shares?

During the previous two years, 35 institutional investors and hedge funds held shares of ESSA Pharma. The most heavily invested institutionals were Bellevue Group AG ($47.75M), PFM Health Sciences LP ($16.62M), Janus Henderson Group PLC ($9.98M), Tang Capital Management LLC ($7.70M), BML Capital Management LLC ($7.56M), Soleus Capital Management L.P. ($4.05M), and Altium Capital Management LLC ($2.56M).Learn more on EPIX's institutional investors.

What percentage of ESSA Pharma stock is owned by institutional investors?

75.12% of ESSA Pharma stock is owned by institutional investors. Learn more on EPIX's institutional investor holdings.

Which institutional investors have been buying ESSA Pharma stock?

Of the 26 institutional investors that purchased ESSA Pharma stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Tang Capital Management LLC ($4.30M), BML Capital Management LLC ($4.22M), RTW Investments LP ($3.26M), Altium Capital Management LLC ($1.43M), Bank of America Corp DE ($812.30K), Aldebaran Capital LLC ($397.52K), and Two Sigma Investments LP ($211.20K).

How much institutional buying is happening at ESSA Pharma?

Institutional investors have bought a total of 15,745,091 shares in the last 24 months. This purchase volume represents approximately $44.71M in transactions.

Which ESSA Pharma major shareholders have been selling company stock?

Of the 11 institutional investors that sold ESSA Pharma stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: RTW Investments LP ($2.15M), Soleus Capital Management L.P. ($2.03M), PFM Health Sciences LP ($1.16M), Ally Bridge Group NY LLC ($574.97K), Driehaus Capital Management LLC ($236.27K), Schonfeld Strategic Advisors LLC ($229.16K), and Rhenman & Partners Asset Management AB ($141K).

How much institutional selling is happening at ESSA Pharma?

Institutional investors have sold a total of 6,604,317 shares in the last 24 months. This volume of shares sold represents approximately $18.61M in transactions.


Related Companies

This page (NASDAQ:EPIX) was last updated on 4/20/2025 by MarketBeat.com Staff
From Our Partners
Trump’s betrayal exposed
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...
Porter & Company | Sponsored
Trump’s Top Secret $9 Trillion AI Superweapon
Jeff Brown spotted Nvidia at $1. Now he’s revealing a new AI superweapon — and the Musk-connected stocks that ...
Brownstone Research | Sponsored
My prediction is coming true
We've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...
InvestorPlace | Sponsored
Musk’s AI Masterplan – Our #1 AI Stock to Buy Now
Did Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...
Behind the Markets | Sponsored
Claim Your FREE Protection Guide
In the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...
American Alternative | Sponsored
URGENT: Someone's Moving Gold Out of London...
People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...
Golden Portfolio | Sponsored
DOGE officially begins retirement transformation
Elon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...
Altimetry | Sponsored
Altucher: Turn $900 into $108,000 in just 12 months?
We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.
Paradigm Press | Sponsored